한글목차

피하 약물 전달 기기 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2025년 297억 7,000만 달러에서 2026년에는 320억 3,000만 달러에 이르고, CAGR 7.6%로 성장할 전망입니다. 지난 수년간의 성장에는 당뇨병 및 만성질환 유병률 증가, 인슐린 펜 및 펜니들 사용 증가, 병원 및 클리닉 인프라 확충, 첨단 투여기술의 제한적 보급, 피하주사에 대한 인식 증가 등이 주요 요인으로 꼽힙니다.

피하 약물 전달 기기 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 2030년에는 424억 2,000만 달러에 이르고, CAGR은 7.3%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 생물학적 제제 및 종양 치료 확대, 스마트 자동 주사기 도입 증가, 재택치료 환경 확대, 이식형 펌프 기술 발전, 환자 중심 약물 투여 솔루션에 대한 수요 증가 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 자동 주사기 및 스마트 주사기 채택 확대, 재택 및 자가 관리 요법에 대한 선호도 증가, 최소침습적 약물 전달 방법에 대한 수요 증가, 생물학적 제제 및 바이오시밀러 약물 전달 용도 확대, 사용자 친화적 장치 설계를 통한 환자 컴플라이언스 향상 등이 있습니다. 환자 순응도 향상 등을 꼽을 수 있습니다.

당뇨병 및 심혈관 질환(CVD)의 유병률 증가는 향후 몇 년 동안 피하 약물 전달 장치 시장의 성장을 견인할 것으로 예측됩니다. 당뇨병 및 심혈관 질환 증가는 고령화, 부적절한 식습관, 좌식생활, 비만, 사회경제적 격차, 스트레스, 환경적 요인, 예방적 의료서비스 접근성 제한 등의 요인이 영향을 미치고 있습니다. 피하 약물 전달 장치는 혈당 조절을 위해 인슐린 및 기타 치료제를 투여하는 당뇨병 관리, 항응고제 및 지질 저하제와 같은 약물을 투여하는 심혈관 관리에 널리 사용되고 있으며, 이러한 장기적인 질환을 관리하기 위한 편리하고 통제된 접근 방식을 제공합니다. 예를 들어, 미국 연방기관인 질병통제예방센터(CDC)에 따르면 2024년 10월 기준 2023년 심혈관 질환으로 인한 사망자 수는 91만 9,032명으로 전체 사망자 중 약 3분의 1을 차지합니다. 그 결과, 당뇨병 및 심혈관 질환의 부담이 증가하면서 피하 약물 전달 장치 시장의 성장에 기여하고 있습니다.

피하 약물 전달 장치 시장에서 사업을 전개하는 주요 기업들은 대용량 인젝터에 대한 정밀하고 맞춤형 유량 제어를 가능하게 하고, 피하 약물 투여의 정확성과 안전성을 향상시키기 위해 소형 디지털 액체 유량 센서와 같은 첨단 기술 개발에 주력하고 있습니다. 소형 디지털 액체 유량 센서는 소형 용도에서 액체 유량을 정확하게 측정하고 정밀한 모니터링 및 제어를 위한 디지털 출력을 제공하는 소형 부품입니다. 예를 들어, 2024년 5월, 환경 및 유량 센서 솔루션을 제공하는 스위스의 Sensirion AG는 SLD3x 시리즈 센서 플랫폼을 발표했습니다. 이 제품군에는 정밀 유량 측정, 막힘 감지, 인라인 기포 감지, 액체 온도 모니터링 등의 기능을 제공하는 맞춤형 구성이 가능한 고정밀 디지털 액체 유량 센서가 포함되어 있습니다. 이 소형 센서는 대규모 의료기기 제조에 적합하며, 피하 약물 전달에 있어 정확한 용량 관리와 환자 안전성을 향상시키는 데 도움을 줍니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병(M&A)

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Subcutaneous drug delivery devices are medical instruments developed to deliver medications directly into the subcutaneous tissue, which is the layer of fat and connective tissue located just beneath the skin. These devices are commonly used to administer a range of medications, including insulin, hormones, and biologics, offering a convenient and minimally invasive approach to drug delivery.

The primary product types of subcutaneous drug delivery devices include insulin pens, pen needles, injector pens, auto-injectors, and implantable pumps. Insulin pens are portable devices designed for the accurate and convenient delivery of insulin in diabetes care, enabling users to easily measure and inject prescribed doses. These devices are applied in various therapeutic areas such as diabetes, fertility, and oncology, and are used by multiple end users including hospitals and clinics, homecare settings, and ambulatory surgical centers.

Tariffs have impacted the subcutaneous drug delivery devices market by increasing the cost of imported components such as precision needles, electronic modules, and medical-grade plastics. Product segments including smart auto-injectors and implantable pumps are most affected, particularly in Asia-Pacific and Europe where manufacturing relies on cross-border supply chains. These cost pressures have led to higher device prices and delayed adoption in some regions. However, tariffs have also encouraged local manufacturing, supply chain diversification, and innovation in cost-effective subcutaneous delivery technologies.

The subcutaneous drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides subcutaneous drug delivery devices market statistics, including subcutaneous drug delivery devices industry global market size, regional shares, competitors with a subcutaneous drug delivery devices market share, detailed subcutaneous drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the subcutaneous drug delivery devices industry. This subcutaneous drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The subcutaneous drug delivery devices market size has grown strongly in recent years. It will grow from $29.77 billion in 2025 to $32.03 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising prevalence of diabetes and chronic diseases, increasing use of insulin pens and pen needles, growing hospital and clinic infrastructure, limited availability of advanced delivery technologies, increasing awareness of subcutaneous drug administration.

The subcutaneous drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $42.42 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growth in biologics and oncology therapies, increasing adoption of smart auto-injectors, expansion of homecare settings, technological advancements in implantable pumps, rising demand for patient-centric drug delivery solutions. Major trends in the forecast period include rising adoption of auto-injectors and smart injection devices, growing preference for home-based and self-administration therapies, increasing demand for minimally invasive drug delivery methods, expansion of biologic and biosimilar drug delivery applications, improved patient compliance through user-friendly device designs.

The growing prevalence of diabetes and cardiovascular diseases (CVD) is expected to drive the expansion of the subcutaneous drug delivery devices market in the coming years. The rise in diabetes and cardiovascular conditions is influenced by factors such as aging populations, poor dietary habits, sedentary lifestyles, obesity, socioeconomic disparities, stress, environmental influences, and limited access to preventive healthcare services. Subcutaneous drug delivery devices are widely used in diabetes management to administer insulin and other therapies for glycemic control, and in cardiovascular care to deliver medications such as anticoagulants or lipid-lowering agents, offering a convenient and controlled approach to managing these long-term conditions. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based federal agency, cardiovascular disease accounted for 919,032 deaths in 2023, representing nearly one in every three deaths. Consequently, the increasing burden of diabetes and cardiovascular diseases is contributing to the growth of the subcutaneous drug delivery devices market.

Major companies operating in the subcutaneous drug delivery devices market are concentrating on the development of advanced technologies, such as miniature digital liquid flow sensors, to improve the accuracy and safety of subcutaneous drug administration by enabling precise and customizable flow control for large-volume injectors. Miniature digital liquid flow sensors are compact components that accurately measure liquid flow rates in small-scale applications and provide digital outputs for precise monitoring and regulation. For instance, in May 2024, Sensirion AG, a Switzerland-based provider of environmental and flow sensor solutions, introduced the SLD3x series sensor platform. This product line includes highly accurate digital liquid flow sensors with customizable configurations, offering features such as precise flow measurement, occlusion detection, in-line air bubble detection, and liquid temperature monitoring. These compact sensors are well suited for large-scale medical device manufacturing, supporting accurate dosing and enhanced patient safety in subcutaneous drug delivery.

In November 2025, Halozyme Therapeutics, a US-based biopharmaceutical company focused on innovative drug delivery technologies, completed the acquisition of Elektrofi for an undisclosed amount. Through this acquisition, Halozyme seeks to broaden its drug delivery technology portfolio, strengthen its capabilities in developing high-concentration, ready-to-use injectable biologics, and reinforce its position in the rapidly expanding market for patient-friendly subcutaneous delivery solutions. Elektrofi is a US-based biotechnology company that specializes in subcutaneous drug delivery devices.

Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.

North America was the largest region in the subcutaneous drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the subcutaneous drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The subcutaneous drug delivery devices market consists of sales of needles, cartridges, and reservoirs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Subcutaneous Drug Delivery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses subcutaneous drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for subcutaneous drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The subcutaneous drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Insulin Pens; Pen Needles; Injector Pens; Auto-Injectors; Implantable Pumps
• 2) By Application: Diabetes; Fertility; Oncology
• 3) By End-User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers
• Subsegments:
• 1) By Insulin Pens: Disposable Insulin Pens; Reusable Insulin Pens
• 2) By Pen Needles: Standard Pen Needles; Safety Pen Needles
• 3) By Injector Pens: Disposable Injector Pens; Reusable Injector Pens
• 4) By Auto-Injectors: Manual Auto-Injectors; Smart Auto-Injectors
• 5) By Implantable Pumps: Insulin Pumps; Drug Infusion Pumps
• Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Roche Holdings Inc.; Medtronic plc; Eli Lilly and Company; Amgen Inc.; Novo Nordisk A/S; Becton Dickinson and Company; West Pharmaceutical Services Inc.; Gerresheimer AG; Insulet Corporation; SHL Medical AG; Tandem Diabetes Care Inc.; Ypsomed Holding AG; Nemera; Elcam Medical Ltd.; Owen Mumford Ltd.; Haselmeier GmbH; Sensile Medical AG; Enable Injections Inc.; Unilife Corporation; PharmaJet; Oval Medical Technologies Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Subcutaneous Drug Delivery Devices Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Subcutaneous Drug Delivery Devices Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Subcutaneous Drug Delivery Devices Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Subcutaneous Drug Delivery Devices Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Rising Adoption Of Auto-Injectors And Smart Injection Devices
  • 4.2.2 Growing Preference For Home-Based And Self-Administration Therapies
  • 4.2.3 Increasing Demand For Minimally Invasive Drug Delivery Methods
  • 4.2.4 Expansion Of Biologic And Biosimilar Drug Delivery Applications
  • 4.2.5 Improved Patient Compliance Through User-Friendly Device Designs

5. Subcutaneous Drug Delivery Devices Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Homecare Settings
• 5.3 Ambulatory Surgical Centers
• 5.4 Specialty Care Centers
• 5.5 Diagnostic And Treatment Centers

6. Subcutaneous Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Subcutaneous Drug Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Subcutaneous Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Subcutaneous Drug Delivery Devices Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Subcutaneous Drug Delivery Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Subcutaneous Drug Delivery Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Subcutaneous Drug Delivery Devices Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Subcutaneous Drug Delivery Devices Market Segmentation

• 9.1. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
• 9.2. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diabetes, Fertility, Oncology
• 9.3. Global Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers
• 9.4. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Insulin Pens, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Disposable Insulin Pens, Reusable Insulin Pens
• 9.5. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Pen Needles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Standard Pen Needles, Safety Pen Needles
• 9.6. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Injector Pens, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Disposable Injector Pens, Reusable Injector Pens
• 9.7. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Auto-Injectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Manual Auto-Injectors, Smart Auto-Injectors
• 9.8. Global Subcutaneous Drug Delivery Devices Market, Sub-Segmentation Of Implantable Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Insulin Pumps, Drug Infusion Pumps

10. Subcutaneous Drug Delivery Devices Market Regional And Country Analysis

• 10.1. Global Subcutaneous Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Subcutaneous Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Subcutaneous Drug Delivery Devices Market

• 11.1. Asia-Pacific Subcutaneous Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Subcutaneous Drug Delivery Devices Market

• 12.1. China Subcutaneous Drug Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Subcutaneous Drug Delivery Devices Market

• 13.1. India Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Subcutaneous Drug Delivery Devices Market

• 14.1. Japan Subcutaneous Drug Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Subcutaneous Drug Delivery Devices Market

• 15.1. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Subcutaneous Drug Delivery Devices Market

• 16.1. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Subcutaneous Drug Delivery Devices Market

• 17.1. South Korea Subcutaneous Drug Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Subcutaneous Drug Delivery Devices Market

• 18.1. Taiwan Subcutaneous Drug Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Subcutaneous Drug Delivery Devices Market

• 19.1. South East Asia Subcutaneous Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Subcutaneous Drug Delivery Devices Market

• 20.1. Western Europe Subcutaneous Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Subcutaneous Drug Delivery Devices Market

• 21.1. UK Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Subcutaneous Drug Delivery Devices Market

• 22.1. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Subcutaneous Drug Delivery Devices Market

• 23.1. France Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Subcutaneous Drug Delivery Devices Market

• 24.1. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Subcutaneous Drug Delivery Devices Market

• 25.1. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Subcutaneous Drug Delivery Devices Market

• 26.1. Eastern Europe Subcutaneous Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Subcutaneous Drug Delivery Devices Market

• 27.1. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Subcutaneous Drug Delivery Devices Market

• 28.1. North America Subcutaneous Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Subcutaneous Drug Delivery Devices Market

• 29.1. USA Subcutaneous Drug Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Subcutaneous Drug Delivery Devices Market

• 30.1. Canada Subcutaneous Drug Delivery Devices Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Subcutaneous Drug Delivery Devices Market

• 31.1. South America Subcutaneous Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Subcutaneous Drug Delivery Devices Market

• 32.1. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Subcutaneous Drug Delivery Devices Market

• 33.1. Middle East Subcutaneous Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Subcutaneous Drug Delivery Devices Market

• 34.1. Africa Subcutaneous Drug Delivery Devices Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Subcutaneous Drug Delivery Devices Market Regulatory and Investment Landscape

36. Subcutaneous Drug Delivery Devices Market Competitive Landscape And Company Profiles

• 36.1. Subcutaneous Drug Delivery Devices Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Subcutaneous Drug Delivery Devices Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Subcutaneous Drug Delivery Devices Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Roche Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

37. Subcutaneous Drug Delivery Devices Market Other Major And Innovative Companies

• Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc.

38. Global Subcutaneous Drug Delivery Devices Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Subcutaneous Drug Delivery Devices Market

40. Subcutaneous Drug Delivery Devices Market High Potential Countries, Segments and Strategies

• 40.1 Subcutaneous Drug Delivery Devices Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Subcutaneous Drug Delivery Devices Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Subcutaneous Drug Delivery Devices Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer